Login / Signup

Ultra-low-dose rituximab: Alternative treatment for autoimmune dermatological conditions.

Mayra Alejandra Reyes SotoSonia Chavez-AlvarezLuis A Yamallel-OrtegaPatrizia Elva Aguilar-CalderónAlejandra Perales-GonzálezAlejandra Villarreal-MartinezMinerva Gómez-FloresJorge Ocampo Candiani
Published in: Journal of the European Academy of Dermatology and Venereology : JEADV (2023)
Keyphrases
  • low dose
  • diffuse large b cell lymphoma
  • multiple sclerosis
  • high dose
  • chronic lymphocytic leukemia
  • replacement therapy
  • smoking cessation